Dipna Pharmachem (DPL) | Stock Overview & Key Data
Dipna Pharmachem Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹558.00 on January 29, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Sep 30, 2024
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dipna Pharmachem
DPL
|
228.19M Small-cap | -10.08% | -4.80% | -24.84% | -48.60% | -58.61% | -68.24% | -97.06% | -96.96% | -92.04% | -93.84% | -93.84% |
|
Medplus Health
MEDPLUS
|
108.75B Mid-cap | 2.21% | -8.44% | 5.44% | 7.75% | 7.41% | 0.15% | 10.40% | -18.04% | -18.04% | -18.04% | -18.04% |
|
One Global Service
ONEGLOBAL
|
11.05B Small-cap | 16.81% | 49.06% | 10.17% | 9.68% | 2.93% | 143.76% | 1,875.38% | 6,435.05% | 9,804.69% | 6,239.00% | 6,239.00% |
|
Sastasundar Ventures
SASTASUNDR
|
8.58B Small-cap | -7.90% | -0.76% | -0.39% | -6.65% | -4.75% | 0.57% | -2.95% | -7.26% | 307.99% | 612.04% | 173.38% |
|
Trident Lifeline
TLL
|
3.01B Small-cap | 4.71% | 0.37% | 5.56% | -15.18% | -20.24% | -7.91% | 74.46% | 146.14% | 146.14% | 146.14% | 146.14% |
|
Achyut Healthcare
ACHYUT
|
1.31B Small-cap | -0.15% | 33.47% | 15.44% | 17.50% | 23.68% | 86.78% | -82.04% | -66.67% | -66.67% | -66.67% | -66.67% |
Ownership & Short Interest
Calculate Your Dipna Pharmachem Investment Returns
Long-Term Investment Performance Analysis
Dipna Pharmachem stock price in Jul 2016 was ₹95.50, A ₹1,000.00 lump sum investment in Dipna Pharmachem made 9 years ago would be worth approximately ₹74.76 today, representing a negative return of -92.52%. This translates to an annualized return (CAGR) of -23.03%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is DPL's 52-week high and low?
- In the last 52 weeks, Dipna Pharmachem reached a high of ₹25.66 (on July 10, 2025) and a low of ₹6.66 (on June 2, 2026).
- What is the market cap and P/E ratio for DPL?
- Curious about Dipna Pharmachem's size and valuation? Its market capitalization stands at 228.19M. When it comes to valuation, the P/E ratio (trailing twelve months) is 10.09, and the forward P/E (looking ahead) is N/A.
- Does DPL pay dividends? If so, what's the yield?
- Yes, Dipna Pharmachem is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 23.16%, and the company has paid an average of ₹6.00 per share annually over the past 3 years.
- Who are Dipna Pharmachem's main competitors or similar companies to consider before investing?
When looking at Dipna Pharmachem, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Medplus Health
MEDPLUS108.75B Healthcare Pharmaceutical Retailers 0.15% 10.40% One Global Service
ONEGLOBAL11.05B Healthcare Pharmaceutical Retailers 143.76% 1,875.38% Sastasundar Ventures
SASTASUNDR8.58B Healthcare Pharmaceutical Retailers 0.57% -2.95% Trident Lifeline
TLL3.01B Healthcare Pharmaceutical Retailers -7.91% 74.46% Achyut Healthcare
ACHYUT1.31B Healthcare Pharmaceutical Retailers 86.78% -82.04% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Dipna Pharmachem Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Dipna Pharmachem's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.24%, the Debt to Equity ratio from the most recent quarter is 23.42, and its Gross Profit Margin stands at 44.45%.
- What is the recent revenue and earnings growth for DPL?
- Looking at Dipna Pharmachem's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -20.20%, and quarterly earnings saw a YoY growth of 319.10%.
- How much of DPL stock is held by insiders and institutions?
- Wondering who owns Dipna Pharmachem stock? Company insiders (like executives and directors) hold about 51.68% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.